MedPath

Effect of a Resilience Model-Based Program for Patients With Newly Diagnosed Colorectal Cancer

Not Applicable
Completed
Conditions
Colorectal Cancer (MSI-H)
Registration Number
NCT03277235
Lead Sponsor
National Taiwan University Hospital
Brief Summary

To develop a resilience model-based cancer prehabilitation program and evaluate its efficacy in improving resilience, alleviating symptoms, and enhancing spiritual well-being in patients with newly diagnosed colorectal cancer.

Detailed Description

Develop and evaluate the effect of a resilience model-based total care plan on reducing fear of recurrence and GI symptom distress, resilience and improving spiritual well-being in this population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Resilience scaleChange from baseline resilience at 12 months

The questionnaire includes 25 items to assess levels of resilience

Secondary Outcome Measures
NameTimeMethod
Symptom Severity ScaleChange from baseline symptom at 12 months

The questionnaire includes 24 items to assess symptom severity

Fatigue Symptom InventoryChange from baseline fatigue at 12 months

The questionnaire includes 14 items to assess fatigue

Center for Epidemiological Studies Depression ScaleChange from baseline depressive symptoms at 12 months

The questionnaire includes 20 items to assess depressive symptoms

Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being ScaleChange from baseline spiritual well-being at 12 months

The questionnaire includes 12 items to assess spiritual well-being

Fear of Cancer Recurrence Inventory-Short FormChange from baseline fear of cancer recurrence at 12 months

The questionnaire includes 9 items to assess fear of cancer recurrence

Trial Locations

Locations (1)

National Taiwan University

🇨🇳

Taipei, Taiwan

National Taiwan University
🇨🇳Taipei, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.